Search Results - Mark Fynn~

Suggested Topics within your search.
  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Patient heterogeneity in dose-finding trials part 1, methods for 2 groups/

    Patient heterogeneity in dose-finding trials part 1, methods for 2 groups/

    Published 2018
    Get full text
    Series
    Electronic Video
    Save to List
    Saved in:
  2. 2
    Patient heterogeneity in dose-finding trials part 1, methods for 2 groups/

    Patient heterogeneity in dose-finding trials part 1, methods for 2 groups/

    Published 2018
    Get full text
    Series
    Electronic Video
    Save to List
    Saved in:
  3. 3
    Patient heterogeneity in dose-finding trials part 1, methods for 2 groups/

    Patient heterogeneity in dose-finding trials part 1, methods for 2 groups/

    Published 2018
    Get full text
    Series
    Electronic Video
    Save to List
    Saved in:
  4. 4
    Patient heterogeneity in dose-finding trials part 2, more than 2 groups /

    Patient heterogeneity in dose-finding trials part 2, more than 2 groups /

    Published 2018
    Get full text
    Series
    Electronic Video
    Save to List
    Saved in:
  5. 5
    Patient heterogeneity in dose-finding trials part 2, more than 2 groups /

    Patient heterogeneity in dose-finding trials part 2, more than 2 groups /

    Published 2018
    Get full text
    Series
    Electronic Video
    Save to List
    Saved in:
  6. 6
    Patient heterogeneity in dose-finding trials part 2, more than 2 groups /

    Patient heterogeneity in dose-finding trials part 2, more than 2 groups /

    Published 2018
    Get full text
    Series
    Electronic Video
    Save to List
    Saved in:
  7. 7
    Polypharmacology in drug discovery

    Polypharmacology in drug discovery

    Published 2012
    Table of Contents: “…7.5 Conclusions. 8 Polypharmacological kinase inhibitors: new hopes for the therapy of cancer Annalisa Petrelli 8.1 Targeted therapies: a new era in the treatment of cancer. 8.2 The single-targeted therapy. 8.3 From single to multi-targeted drugs in cancer therapy. 8.4 Polypharmacology kinase inhibitors in clinical practice and under development. 8.5 Concluding remarks. 9 Polypharmacology as an emerging trend in antibacterial discovery Lynn L. Silver 9.1 Introduction. 9.2 Classical antibacterial polypharmacology. 9.3 New approaches to multi-targeted single pharmacophores. 9.4 Synthetic lethals. 9.5 Hybrid molecules. 9.6 Conclusions. 10 A "magic shotgun" perspective on anticonvulsant mechanisms Matt T. …”
    An electronic book accessible through the World Wide Web; click to view
    Electronic eBook
    Save to List
    Saved in:

Search Tools: